Electromed Shares Rise on Higher Sales, Profit

Dow Jones
Aug 27, 2025

By Katherine Hamilton

 

Electromed shares rose after the company said fiscal fourth-quarter sales and income rose.

The stock advanced 10% to $22.80 during after-hours trading Tuesday. At close, it was down 30% this year.

The health company, which specializes in technology designed to clear airways, said Tuesday its revenue increased 17% to $17.4 million in the three months ended on June 30. Its profit was $2.2 million, or 25 cents a share, compared with $1.8 million, or 20 cents a share, the year before.

Sales in Electromed's direct homecare business rose 15% primarily due to incremental referrals and approvals driven by an increase in direct sales representatives and higher revenue per approval.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

August 26, 2025 17:44 ET (21:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10